This survey of the international experience with lung transplantation for patients with bronchogenic carcinoma in the explanted lung demonstrates three important findings: (1) few patients with stage I bronchogenic carcinoma develop recurrences, (2) most patients with stage II and III bronchogenic carcinoma develop recurrences and die within 1 year of transplant because of widespread metastasis, and (3) most patients with multifocal BAC develop recurrences, but recurrence is usually limited to the transplanted lung and is slow growing despite the immunosuppressive therapy.